Pictet Asset Management Holding Sa Madrigal Pharmaceuticals, Inc. Transaction History
Pictet Asset Management Holding Sa
- $93.5 Billion
- Q2 2025
A detailed history of Pictet Asset Management Holding Sa transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 208,266 shares of MDGL stock, worth $93.6 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
208,266
Previous 207,043
0.59%
Holding current value
$93.6 Million
Previous $68.6 Million
8.09%
% of portfolio
0.07%
Previous 0.08%
Shares
8 transactions
Others Institutions Holding MDGL
# of Institutions
356Shares Held
23.2MCall Options Held
738KPut Options Held
473K-
Janus Henderson Group PLC London, X02.19MShares$985 Million0.34% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.09MShares$940 Million32.86% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$896 Million9.27% of portfolio
-
Baker Bros. Advisors LP New York, NY1.98MShares$888 Million6.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.88MShares$844 Million0.01% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $7.69B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...